</Agent System Instructions>
<Blinded Review: TIME_ANON_0227>
**Composite Score:** 3.8 / 10.0 (Rigor: 1.2/3.5 | Claims: 1.1/2.5 | Biology: 0.9/2.0 | Reproducibility: 0.6/2.0)
**Bias Category:** Statistical/Design
**Verdict:** Reject (Fundamental Flaws)
**Study Modality:** Hybrid Computational + Wet-Lab
**Technology Maturity:** Commodity/Hype-Cycle Template
**Epistemic Stage:** Basic/Mechanistic Discovery

---

### 1. Executive Summary
This study performs bulk RNA-seq profiling of primary porcine alveolar macrophages (PAMs) infected with wild-type African swine fever virus (ASFV-WT, JS strain) or an MGF360-4L deletion mutant (ASFV$\Delta$MGF360-4L) vs. mock controls at 6 and 16 hours post-infection ($n = 3$ biological replicates per group, 18 libraries total). While using primary PAMs in an ABSL-3 setting with a defined deletion mutant is biologically relevant, the manuscript is a superficial, unvalidated commercial sequencing report containing incomplete methods sentences, unadjusted $p$-value thresholds for differential expression, zero experimental validation (no RT-qPCR, Western blot, or viral growth curve controls), and no public deposition of the sequencing data.

### 2. Methodological & Statistical Audit
- **Unadjusted $p$-values in Genome-Wide Differential Expression:** In Section 2.8 and Section 3.3, differentially expressed genes (DEGs) were called in `DESeq2 v1.38.0` using raw, unadjusted $p < 0.05$ and $\text{Fold Change} \ge 1.5$ ($|\log_2\text{FC}| \ge 0.585$). Failing to control the false discovery rate (e.g., Benjamini-Hochberg $p_{\text{adj}} < 0.05$) across $\sim 20,000$ porcine genes guarantees hundreds of false-positive DEGs, which directly undermines the reported 22 DEGs at 6 hpi and 342 DEGs at 16 hpi between AW and AC groups.
- **Uncontrolled Confounding by Viral Replication Kinetics:** The authors infect PAMs at $\text{MOI} = 1$, but never measure or report viral replication titers, viral transcript abundance, or infection efficiency comparing ASFV-WT vs. ASFV$\Delta$MGF360-4L at 6 and 16 hpi. Without demonstrating equivalent viral load or normalizing for viral replication differences at 16 hpi, it is impossible to tell whether the 342 host DEGs reflect a specific function of MGF360-4L or simply attenuated replication of the $\Delta$MGF360-4L mutant.
- **Template Editing Omissions in Methods:**
  - Section 2.6 states: *"The version of the reference genome used is Hisat2 (version 2.1.0) was used to align clean reads..."* — the actual *Sus scrofa* reference genome assembly version (e.g., Sscrofa11.1) and annotation release were accidentally deleted from the vendor report template.
  - Section 2.7 states: *"FPKM is a standardized index for measuring the expression level of transcripts or genes, and its calculation formula is as follows:"* followed by a blank line where the equation was omitted.

### 3. Biological / Experimental Grounding & Claim Proportionality
- **Claim 1:** Both ASFV-WT and ASFV$\Delta$MGF360-4L upregulate innate immune and interferon-stimulated genes (TLR3, ISG15, ISG20, OAS1/2, MX1/2, IFIT2/3/5) in PAMs at 6 and 16 hpi. `[Moderately Supported]` by RNA-seq heatmaps, though completely lacking orthogonal RT-qPCR or protein validation.
- **Claim 2:** MGF360-4L deletion specifically reprograms host aminoacyl-tRNA biosynthesis at 16 hpi, providing a mechanistic reference for ASFV immune evasion and control. `[Overstated]` — this claim rests entirely on a single KEGG pathway enrichment scatter plot (Figure 5C) derived from unadjusted $p < 0.05$ DEGs without a single validation assay, gene-level expression table, or functional experiment testing aminoacyl-tRNA synthetases.
- **Contradiction with Introduction:** In the Introduction (line 16), the authors state that MGF360-4L degrades RIPK3 and degrades MDA5 via SQSTM1/p62-mediated autophagy to inhibit IRF3 phosphorylation and type I IFN, yet in their Results (Section 3.6, Figure 6) both ASFV-WT and ASFV$\Delta$MGF360-4L strongly induce ISGs and IFN$\beta$1 without any quantitative comparison showing higher IFN$\beta$1 or ISG induction in the $\Delta$MGF360-4L mutant vs. WT.

### 4. Reproducibility & Data Completeness
- **Missing Raw Data & Accession Numbers:** Despite conducting an 18-sample RNA-seq study, the Data Availability Statement claims *"All data generated for this study are included in the article."* No NCBI SRA, GEO, or GSA accession number is provided for the raw FASTQ files or count matrices, nor are supplementary DEG tables included.
- **Missing Reference Genome & Parameter Details:** As noted above, the *Sus scrofa* genome assembly build, gene annotation GTF version, and sequencing platform/read-length specifications are missing.
</Blinded Review: TIME_ANON_0227>
